Peter R. Fried, M.D
Dr. Fried is board certified in therapeutic radiology. His specialty is radiation therapy. After graduating from medical school at the Medical College of Virginia, he completed a residency at New York University Medical Center. Sarcoma, testicular cancer, and bone marrow transplantation are areas of interest for Dr. Fried.
Bone Marrow Transplantation
Medical College of Virginia
New York University Medical Center
New York University Medical Center
CERTIFICATIONS & LICENSURES
American Board of Therapeutic Radiology
OHC Board of Directors
Director, Gamma Knife Program at Mercy Health Jewish Hospital
Director, Cyberknife Program, The Urology Group
Fried, Peter R. "The Changing Trends in Cancer Care." ohcare.com. July 15, 2013.
Cooper JS, Fried PR, Laubenstein LJ: Initial Observations of the Effect of Radiotherapy on Epidemic Kaposi’s Sarcoma. JAMA 259:934-935, 1984: JAMA (French Translation) 89:845-847
Fried PR, Cooper JS, Balthazar E, Fazzinni E, Newall J: A Role for Radiotherapy in Treatment of Solid and Papillary Neoplasms of the Pancreas. Cancer, 56:2783:2785, 1985
Cooper JS, Fried PR: Four Years Experience in The Therapeutic Treatment of Epidemic Kaposi’s Sarcoma (abstract). Inst. J Rad. Onc. Biol. Phys. 11 (suppl 1): 178
Cooper JS, Fried PR: Toxicity of Oral Radiotherapy in Patients Having AIDS. Archives of Otolaryngology. Arch Otolaryngol Head Neck Surg; 327-28, 1987
Fried PR, Gliedman P, Ho A, Beller U, Balthazar E, Steinfeld AD, Cooper JS: Efficacy of CT Scanning in Staging of Cervical Cancer. Proc. Amer. Soc. Clin. Onc. 5:14, 1986
Fried PR, Steinfeld R, Cassileth BR, Steinfeld AD: Incidence of Developmental Handicaps Among the Offspring of Men Treated for Testicular Seminoma. Int. J. of Andrology; 10 (1):385-87, 1987
Cooper JS, Fried PR: Defining the Role of Radiation Therapy in the Management of Epidemic Kaposi’s Sarcoma. Int. J. Rad. Onc. Biol. Phys; 13 (1):35-39, 1987
Fried PR, Mandell S: The Role of Adjuvant Radiotherapy Following the Radical Prostatectomy For Microscopic Residual Disease. European Urology; 15 (1-2):37-39, 1988
Dattoli MJ, Gretz HF, Fried PR: Analysis of Multiple Prognostic Factors in Patients with Stage 1B Cervical Cancer: Age As A Major Determinant. Int. J. Rad. Onc. Biol. Phys. 17:35-40, 1989
As a member of our OHC physician team, Dr. Fried has full access to the OHC Clinical Trial research program.
We encourage our patients to discuss all of their healthcare options — including Clinical Trial research programs — with their doctor.
The following are recent reviews provided by actual OHC patients:
"Dr. Peter Fried is always prompt when seeing me at the office. He expresses "genuine concern" for my health in general, as well as my prostate condition. All personnel were very patient, kind and thorough. Dr. Fried also included my wife during my checkup and made sure she understood everything we discussed."
"Dr. Fried has been very helpful in managing my case, and I have complete confidence in his skills."
"I have had such a great experience with Dr. Fried that I felt compelled to tell my story. He has been everything that I would want in a physician during this difficult period. He is always willing to give me all the time I need, the answers to all my questions, and the medical expertise required to get me through this. I have recommended him to a number of people in my circle, and just wanted everyone to know what a valuable asset he is to OHC."